Living Donor Lung Transplantation for Pleuroparenchymal Fibroelastosis

详细信息    查看全文

• 作者：Atsushi Hata ; MD^a ; Takahiro Nakajima ; MD ; PhD^a ; ^{takahiro_nakajima@med.miyazaki-u.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Shigetoshi Yoshida ; MD ; PhD^a ; Taku Kinoshita ; MD^b ; Jiro Terada ; MD ; PhD^b ; Koichiro Tatsumi ; MD ; PhD^b ; Goro Matsumiya ; MD ; PhD^c ; Hiroshi Date ; MD ; PhD^d ; Ichiro Yoshino ; MD ; PhD^a
• 刊名：The Annals of Thoracic Surgery
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：101
• 期：5
• 页码：1970-1972
• 全文大小：809 K

文摘

We report the first patient with pleuroparenchymal fibroelastosis (PPFE) to undergo living donor bilateral lobar lung transplantation. The patient was diagnosed with secondary PPFE as a late complication of chemotherapy that included high-dose cyclophosphamide for mature B-cell lymphocytic leukemia. Although the patient maintained complete remission, dry cough and back pain appeared 8 years after the chemotherapy. He had repeated bilateral pneumothoraces, and his respiratory condition gradually deteriorated because of progressive pleural thickening and parenchymal fibrosis. He underwent living-donor bilateral lobar lung transplantation with an inverse transplant on the left side.